ONCOVISTA INNOVATIVE THERAPIES, INC: 10-Q filed 2012-08-14
What ONCOVISTA INNOVATIVE THERAPIES, INC reported in its quarterly report filed 2012-08-14 (fiscal Q2 2012): 25 published measures, 70 facts as tagged in accession 0001144204-12-045889.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-08-14
- Fiscal period
- fiscal Q2 2012
- Accession
- 0001144204-12-045889 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ONCOVISTA INNOVATIVE THERAPIES, INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 1,306,821 | USD | |
| At 2011-12-31 | 2,188,619 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -996,161 | USD | |
| At 2011-12-31 | -124,028 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 1,165,612 | USD | |
| At 2011-12-31 | 2,125,229 | USD | |
| At 2011-06-30 | 2,748,515 | USD | |
| At 2010-12-31 | 3,524,496 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -959,874 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -773,122 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 0 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 0 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 0 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -21,189,724 | USD | |
| At 2011-12-31 | -20,279,739 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 6,732 | USD | |
| At 2011-12-31 | 10,222 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 37,595 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 71,373 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -565,493 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -1,053,094 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -552,941 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -1,011,335 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 1,300,089 | USD | |
| At 2011-12-31 | 2,178,397 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 3,476 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 6,845 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 12,636 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 13,473 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 2,302,982 | USD | |
| At 2011-12-31 | 2,312,647 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 825,005 | USD | |
| At 2011-12-31 | 818,522 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 565,493 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 1,053,094 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 552,941 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 1,011,335 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 341,402 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 640,227 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 179,940 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 341,990 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 21,627,868 | shares | |
| At 2011-12-31 | 21,370,725 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 39,458 | USD | |
| At 2011-12-31 | 39,458 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -32,726 | USD | |
| At 2011-12-31 | -29,236 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 1,127,331 | USD | |
| At 2011-12-31 | 1,003,580 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -250,557 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -909,985 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -577,932 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -1,317,437 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 224,091 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 412,867 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 373,001 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 669,345 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 3,490 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 3,251 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 883 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 883 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 7,049 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 4,920 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 314,936 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 143,109 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -24,991 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -306,102 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 6,483 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 86,639 | USD | 181 |
Inspect the source
- Entity
- ONCOVISTA INNOVATIVE THERAPIES, INC / CIK 0001094847
- Captured
- SEC response SHA-256
034ecc655296ec55707e21b2011e7bc05aab2b1bd1d5e47c9d631e0e4310eac5
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001094847.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))